Lactobacillus strains derived from human gut ameliorate metabolic disorders via modulation of gut microbiota composition and short-chain fatty acids metabolism
- 15 June 2021
- journal article
- research article
- Published by Brill in Beneficial Microbes
- Vol. 12 (3), 267-282
- https://doi.org/10.3920/bm2020.0148
Abstract
Regulation on gut microbiota and short-chain fatty acids (SCFAs) are believed to be a pathway to suppress the development of metabolic syndrome. In this study, three Lactobacillus strains derived f...This publication has 61 references indexed in Scilit:
- The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43Nature Communications, 2013
- Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatmentEMBO Molecular Medicine, 2011
- Modulation of immune homeostasis by commensal bacteriaCurrent Opinion in Microbiology, 2011
- Nutrient sensing and inflammation in metabolic diseasesNature Reviews Immunology, 2008
- Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cellsJournal of Hepatology, 2008
- Will All Americans Become Overweight or Obese? Estimating the Progression and Cost of the US Obesity EpidemicObesity, 2008
- Human gut microbes associated with obesityNature, 2006
- Inflammation and metabolic disordersNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- A humanized gnotobiotic mouse model of host–archaeal–bacterial mutualismProceedings of the National Academy of Sciences of the United States of America, 2006